The Africa Health Ventures Podcast Rowena Luk

In 10 years, the medicine supply chain in Africa will look very different than it does today. In Part 2 of this podcast, we examine four key trends which are going to re-shape the medicine supply chain in Africa over the next decade - and shout out to a few of the entrepreneurs that are leading the charge. From regulatory changes spearheaded by the African Union to biomedical innovation requiring new pathways to patient, the medicine market is both growing and changing in Africa.
Our lineup includes:
* Mila Nepomnyashchiy, Lead Advisor, Center for Innovation and Impact, USAID
* Sidharth Rupani, Senior Advisor for Supply Chain, The Global Fund
* Yusuf Rasool, Director of Global Market Access at MSD/Merck
* Clinton De Souza, former Director of Public Health for Imperial Logistics (now DP World), Managing Partner at Celsian Consulting
* Dr. Prashant Yadav, one of the world’s leading scholars on healthcare supply chains. Dr Yadav is a Senior Fellow at the Center for Global Development, Affiliate Professor at INSEAD and Lecturer at Harvard Medical School
Listen now wherever you get your podcasts (Apple Podcasts, Spotify, Overcast, etc.).
In case you missed it, don't forget to check out Part 1 of this episode, where we trace the movement of a pack of medicines from a factory in India to the shelves of a mom-and-pop pharmacy in Zambia. 
Connect with Africa Health Ventures
📰 Sign up for our newsletter to stay informed about what’s going on with healthcare ventures in Africa
🪙 Nominate a startup for seed funding
🤝 Invest with us
👍 Follow us on LinkedIn
🎙️ Subscribe to this podcast
Show Notes
Part 2 of The Medicine Supply Chain in Africa covers 3 segments:
1. The Outsized Role of Global Donors
(3m22s) - There’s a world of difference between the private sector medicine markets and the ones supported by billions of dollars of international donor funding. We hear from Mila Nepomnyashchiy of USAID about two different worlds: one for the medicines endorsed by global funding… and one for everything else.
2. Four Trends That Will Dramatically Change The Medicine Supply Chain in the Next 10 Years
(5m45s) - Trend 1: Clinton De Souza, former Director of Public Health for Imperial Logistics (now DP World), on regulatory changes from the African Union that will massively expand the size of the market.
(9m44s) - Trend 2: Yusuf Rasool, Director of Global Market Access at MSD/Merck, on vertically integrated supply chains that will reduce costs and increase access to consumers.
(13m28s) - Trend 3: Dr. Prashant Yadav of the Center for Global Development on omnichannel distribution that will meet patients where they live and work.
(16m46s) - Trend 4: Sidharth Rupani, Senior Advisor for Supply Chain at The Global Fund, on the golden age of biomedical innovation that will challenge our existing ideas of both ‘medicines’ and ‘supply chain’.
3. Social Entrepreneurs Leading the Charge
(20m31s) - Dr. Prashant Yadav highlights a handful of social enterprises that are leading the charge for change.
Learn More
* USAID’s Global Health Supply Chain Program is a US$9.5 billion program with support from PEPFAR. The follow-in contract may be as much as US$17 billion.
* The Global Fund provides extensive support to countries in procuring low-cost, priority medicines. Every year it spends about US$2 billion to procure medicines for HIV, tuberculosis, and malaria.
* The Africa Medical Supplies Platform is a pooled procurement mechanism spearheaded by the African Union
* The African Medicines Agency seeks to create a common regulatory environment for medicines across Africa
* The African Continental Free Trade Agreement could create the largest free trade area in the world
* mPharma provides medicines to pharmacies, but does not require payment until those medicines are sold. This helps pharmacies to stock more medicines by de-risking the need for upfront cash.
* Maisha Meds is providing forecasting, sourcing, and oth

What does it take to move a pack of medicines from a factory in India to the shelves of a mom-and-pop pharmacy in Zambia? In this episode, we explore the world of the medicine supply chain in Africa, as told by the people who run it. Along the way, we unpack the market dynamics which limit access to low-cost, essential medicines.
Our lineup includes:
* Yusuf Rasool, Director of Global Market Access at MSD/Merck
* Clinton De Souza, former Director of Public Health for Imperial Logistics (now DP World), Managing Partner at Celsian Consulting
* Michael Moreland, CEO and Founder, Field Intelligence
* Sidharth Rupani, Senior Advisor for Supply Chain, The Global Fund
* Mila Nepomnyashchiy, Lead Advisor, Center for Innovation and Impact, USAID
* Dr. Prashant Yadav, Senior Fellow at the Center for Global Development, Affiliate Professor at INSEAD and Lecturer at Harvard Medical School
Listen now wherever you get your podcasts (Apple Podcasts, Spotify, Overcast, etc.).
Stay tuned for Part 2, when we look at the future trends which are going to dramatically change this supply chain and highlight a few of the new ventures which are leading the way.
Connect with Africa Health Ventures
📰 Sign up for our newsletter to stay informed about what’s going on with healthcare ventures in Africa
🪙 Nominate a startup for seed funding
🤝 Invest with us
👍 Follow us on LinkedIn
🎙️ Subscribe to this podcast
In this episode, we cover
* (2m54) - Setting the stage: we introduce several of the key actors in the medicine supply chain, including manufacturers, distributors, and pharmacies. Dr. Prashant Yadav highlights the key role of Ministries of Health as well as the disruptive influence of social entrepreneurs.
* (8m27s) - Yusuf Rasool of MSD/Merck describes the role of large pharmaceutical companies and why it is difficult for a large multinational to operate directly in 54 different African countries.
* (10m57s) - Clinton De Souza digs into two of the structural problems in the medicines market which makes it difficult for distributors to deliver low-cost essential medicines.
* (19m07s) - From the perspective of Five Star Pharmacy in Zambia, we look at the working capital gap which prevents small pharmacies from making the full range of medicines available to people.
* (21m49s) - Michael Moreland of Field Intelligence describes the role of social entrepreneurs and embedded financing in allowing small pharmacies to increase product availability.
* (29m17s) - Recap of the episode so far and teaser for Part 2
Learn More
* Health Product Supply Chains in Developing Countries - This 2015 paper from Dr. Prashant Yadav summarizes the key actors and common challenges of medicine supply chains in Sub-Saharan Africa.
* How Local Innovation Can Drive the Global Development Agenda - This 2023 piece from Dr. Prashant Yadav highlights the importance of new social entrepreneurs in addressing gaps in the private and public medicine supply chain.
* Innovations in Digitizing Health Supply Chains in Africa - This 2023 market intelligence report from Salient Advisory highlights some of the key areas of the medicine supply chain where startups in Africa are most active.
* How MSD/Merck is improving access to healthcare - This page highlights a few of the affordability solutions that MSD/Merck’s Access to Medicines team is working on around the world.
* Imperial Logistics is one of the largest medicine distributors on the African continent.
* Five Star Pharmcies is a chain of retail pharmacies in Zambia founded by Lloyd Matowe with the support of Clinton De Souza.
* Field Intelligence is a social enterprise providing planning, fulfilment, and financing of pharmaceuticals to over 35,000 points of care in Nigeria and Kenya, including government clinics, retail pharmacies and drug shops, hospitals and telehealth providers.
* Was the $9.5B health supply chain 'a waste of USAID's money'? - Earlier this month, Devex published a(nother) searin

Unlocking access to quality healthcare in Africa by 2030 will require radical innovations. Join veteran digital health / healthtech entrepreneur Rowena Luk in conversation with healthcare industry leaders and innovators every quarter to strategize on what the future of healthcare in Africa will look like. This podcast is for social entrepreneurs, impact investors, and global health professionals who need to stay ahead of the rapidly changing landscape of healthcare in Africa.
Subscribe to our newsletter at AfricaHealthVentures.com/Subscribe


Get full access to Africa Health Ventures at rowenaluk.substack.com/subscribe

Chuck Slaughter is the founder of Living Goods, which supports over 10,000 digitally-empowered community health workers who are reducing child deaths by over 25% at an annual cost of under $4 per person. As a Senior Advisor to TPG Rise (a $10 billion impact investing platform), Director of the Horace W. Goldsmith Foundation, and a successful entrepreneur, Chuck has a rich perspective on how digital is reshaping aid and development work. Tune in today to hear Chuck’s guidance on whether to ‘build or buy’ tech, why nonprofits struggle to deliver the best technology products, and how governments and the private sector need to work together to scale high-impact innovations.

Chuck serves on the boards of Yale’s School of Management, Tidepool, Reach Health, and the Horace W Goldsmith Foundation. He received a Skoll Award for Social Entrepreneurship, an Ernst and Young Entrepreneur of the Year Award, a Draper Richards Kaplan Fellowship, and is a World Economic Forum Social Entrepreneur of the Year. 

A Few Highlights
(6m27s) - How Chuck and Living Goods became digital first
(13m45s) - The DESC metaphor of Living Goods: Digital, Equipped, Supervised and Compensated
(22m01s) - Working with new technologies: the 'build or buy' debate
(28m24s) - Why nonprofits struggle to build great tech
(32m09s) - The digital transformation of aid: grantmaking through the Horace W. Goldsmith Foundation
(37m08s) - Financing scale: how governments and the private sector need to work together
(40m19s) - Rapid fire questions, shoutouts, and recommendations

You can learn more about Living Goods on their website at livinggoods.org. 

 

Let us know what you thought of this episode on LinkedIn or Twitter (@AidEvolved). You can also access show notes at AidEvolved.com.


Get full access to Africa Health Ventures at rowenaluk.substack.com/subscribe

Dr. Agnes Binagwaho is a pediatrician, former Minister of Health of Rwanda, Senior Lecturer at Harvard University, Advisor to the Director-General of the WHO, and co-founder of the University of Global Health Equity. 

She joins us today to talk about the role of technology in the remarkable transformation of Rwanda’s health system post-genocide. 

What are the failed promises of health technology? How has data been a North Star to her work? And what does it take to show the world that Rwanda today stands for truth?

 

Highlights

(02m59s) - When health data is held hostage 
(04m21s) - HIV is a curse that ushered in the era of electronic medical records
(10m06s) - How epidemiological data supports effective health systems governance
(16m10s) - Using Twitter to take a stand
(20m54s) - Whose data do you trust?

 

Submit a question or comment to our mailbag, and we’ll discuss it on a future show. Emails or voice recordings can be sent to podcast@aidevolved.com 

Connect with us on LinkedIn or Twitter (@AidEvolved) and access show notes at https://AidEvolved.com

 


Get full access to Africa Health Ventures at rowenaluk.substack.com/subscribe

Dr. Biju Mohandas has led investments at not just one but three different household names in impact investing: LeapFrog Investments, the International Finance Corporation (IFC), and Acumen. Tune in today to hear about his take on the upcoming global healthcare crisis, the competitive edge of entrepreneurs in Africa and India, and the catalytic role of impact investors. Hear the investment priorities of a man who's been leading impact investments in healthcare in Africa as long as the term "impact investing" has existed.

 

Dr. Biju Mohandas is a Partner at LeapFrog and the firm’s Global Co-Leader for Health Investments. Prior to LeapFrog, Dr Mohandas led the IFC’s Healthcare and Education investment team in Sub-Saharan Africa and was the Global Sector Lead for Medical Devices after also serving as head of Acumen in East Africa and as part of their founding team in India.

 

We’ll cover:

(2m35s) – The coming global healthcare crisis
(8m45s) – How Africa and India are poised to leapfrog ahead
(12m11s) – Investing in asset-light healthcare 
(15m09s) – Goodlife Pharmacy’s re-emergence after the Westgate Attack in Nairobi
(18m08s) – How Redcliffe Diagnostics is bringing the lab closer to people in India
(21m38s) – Pervasive technology, IoT, and wellness
(23m04s) – HealthifyMe, the largest digital wellness app in India
(26m13s) – How investors exit from ventures in emerging markets
(30m10s) – Rapid fire questions

 

Submit a question to our mailbag and we’ll discuss it on a future show. Emails or voice recordings can be sent to podcast@aidevolved.com 

 

Connect with us on LinkedIn or Twitter (@AidEvolved) and access Biju’s latest synthesis on the state of healthcare in Africa at https://AidEvolved.com.

 


Get full access to Africa Health Ventures at rowenaluk.substack.com/subscribe